AAPL284.41+0.63 (+0.22%) ▲|ABBV251.15-2.21 (-0.87%) ▼|ABT93.54-0.58 (-0.62%) ▼|ACN129.55+0.57 (+0.44%) ▲|ADBE207.80+5.07 (+2.50%) ▲|AMAT658.51+31.67 (+5.05%) ▲|AMD526.32+4.74 (+0.91%) ▲|AMGN361.66+3.33 (+0.93%) ▲|AMT174.67-0.93 (-0.53%) ▼|AMZN240.66+7.97 (+3.43%) ▲|AVGO372.28+7.26 (+1.99%) ▲|AXP341.60+1.40 (+0.41%) ▲|BA218.56+1.38 (+0.63%) ▲|BAC58.13+0.32 (+0.54%) ▲|BKNG184.09+2.63 (+1.45%) ▲|BLK959.39-4.21 (-0.44%) ▼|BMY57.74+0.24 (+0.42%) ▲|BNY145.69+2.27 (+1.58%) ▲|BRK-B498.31+1.07 (+0.22%) ▲|C142.85+1.18 (+0.83%) ▲|CAT1,006.24+8.22 (+0.82%) ▲|CL92.23+0.17 (+0.18%) ▲|CMCSA25.49+2.32 (+9.99%) ▲|COF204.27+0.32 (+0.16%) ▲|COP105.80+0.10 (+0.09%) ▲|COST963.85+11.31 (+1.19%) ▲|CRM159.55+1.25 (+0.79%) ▲|CSCO116.65+2.88 (+2.53%) ▲|CVS103.67-0.65 (-0.62%) ▼|CVX170.72-0.19 (-0.11%) ▼|DE612.44-0.81 (-0.13%) ▼|DHR194.09-1.74 (-0.89%) ▼|DIS99.71+1.01 (+1.02%) ▲|DUK128.13-0.25 (-0.19%) ▼|EMR143.03-0.42 (-0.29%) ▼|FDX323.51+5.32 (+1.67%) ▲|GD349.37+2.66 (+0.77%) ▲|GE374.42+5.97 (+1.62%) ▲|GEV1,101.80+59.29 (+5.69%) ▲|GILD126.83-1.05 (-0.82%) ▼|GM77.91-0.18 (-0.23%) ▼|GOOG345.01+10.32 (+3.08%) ▲|GOOGL347.24+9.85 (+2.92%) ▲|GS1,035.93+16.32 (+1.60%) ▲|HD348.15-0.72 (-0.21%) ▼|HON248.86+5.45 (+2.24%) ▲|IBM271.02-0.61 (-0.22%) ▼|INTC124.03-4.30 (-3.35%) ▼|INTU275.49+7.77 (+2.90%) ▲|ISRG413.91+9.64 (+2.38%) ▲|JNJ254.70+0.04 (+0.02%) ▲|JPM330.35+1.30 (+0.39%) ▲|KO83.13+0.50 (+0.61%) ▲|LIN519.02-0.60 (-0.12%) ▼|LLY1,222.76+14.64 (+1.21%) ▲|LMT507.62+0.22 (+0.04%) ▲|LOW220.10-2.38 (-1.07%) ▼|LRCX389.88+10.79 (+2.85%) ▲|MA508.72+9.70 (+1.94%) ▲|MCD269.90+0.14 (+0.05%) ▲|MDLZ60.70-0.09 (-0.15%) ▼|MDT81.20+0.22 (+0.27%) ▲|META568.16+17.91 (+3.25%) ▲|MMM165.10+1.09 (+0.66%) ▲|MO73.65-0.14 (-0.19%) ▼|MRK128.07-0.59 (-0.46%) ▼|MS215.20+3.17 (+1.50%) ▲|MSFT379.04+6.07 (+1.63%) ▲|MU1,086.02-46.32 (-4.09%) ▼|NEE88.09-0.48 (-0.54%) ▼|NFLX75.47+1.66 (+2.25%) ▲|NKE41.13+0.38 (+0.92%) ▲|NOW101.84+3.50 (+3.56%) ▲|NVDA195.11+2.58 (+1.34%) ▲|ORCL152.60+4.07 (+2.74%) ▲|PEP140.79-0.60 (-0.42%) ▼|PFE24.35+0.06 (+0.23%) ▲|PG147.81-1.21 (-0.81%) ▼|PLTR118.08+5.15 (+4.56%) ▲|PM179.97-0.81 (-0.45%) ▼|QCOM190.75+1.36 (+0.72%) ▲|RTX188.95+0.96 (+0.51%) ▲|SBUX104.63+0.03 (+0.03%) ▲|SCHW91.02+0.35 (+0.38%) ▲|SO96.95-0.21 (-0.22%) ▼|SPG227.56+0.67 (+0.30%) ▲|T21.67-1.06 (-4.64%) ▼|TMO505.55-7.48 (-1.46%) ▼|TMUS175.99-6.69 (-3.66%) ▼|TSLA392.61+12.90 (+3.40%) ▲|TXN287.05+1.62 (+0.57%) ▲|UBER77.48+1.28 (+1.68%) ▲|UNH420.45-7.45 (-1.74%) ▼|UNP271.08+2.73 (+1.02%) ▲|UPS107.75-0.40 (-0.37%) ▼|USB61.07+0.16 (+0.26%) ▲|V342.34+6.11 (+1.82%) ▲|VZ44.07-2.48 (-5.32%) ▼|WFC84.07+0.21 (+0.25%) ▲|WMT116.13+0.44 (+0.38%) ▲|XOM136.37-0.18 (-0.13%) ▼|AAPL284.41+0.63 (+0.22%) ▲|ABBV251.15-2.21 (-0.87%) ▼|ABT93.54-0.58 (-0.62%) ▼|ACN129.55+0.57 (+0.44%) ▲|ADBE207.80+5.07 (+2.50%) ▲|AMAT658.51+31.67 (+5.05%) ▲|AMD526.32+4.74 (+0.91%) ▲|AMGN361.66+3.33 (+0.93%) ▲|AMT174.67-0.93 (-0.53%) ▼|AMZN240.66+7.97 (+3.43%) ▲|AVGO372.28+7.26 (+1.99%) ▲|AXP341.60+1.40 (+0.41%) ▲|BA218.56+1.38 (+0.63%) ▲|BAC58.13+0.32 (+0.54%) ▲|BKNG184.09+2.63 (+1.45%) ▲|BLK959.39-4.21 (-0.44%) ▼|BMY57.74+0.24 (+0.42%) ▲|BNY145.69+2.27 (+1.58%) ▲|BRK-B498.31+1.07 (+0.22%) ▲|C142.85+1.18 (+0.83%) ▲|CAT1,006.24+8.22 (+0.82%) ▲|CL92.23+0.17 (+0.18%) ▲|CMCSA25.49+2.32 (+9.99%) ▲|COF204.27+0.32 (+0.16%) ▲|COP105.80+0.10 (+0.09%) ▲|COST963.85+11.31 (+1.19%) ▲|CRM159.55+1.25 (+0.79%) ▲|CSCO116.65+2.88 (+2.53%) ▲|CVS103.67-0.65 (-0.62%) ▼|CVX170.72-0.19 (-0.11%) ▼|DE612.44-0.81 (-0.13%) ▼|DHR194.09-1.74 (-0.89%) ▼|DIS99.71+1.01 (+1.02%) ▲|DUK128.13-0.25 (-0.19%) ▼|EMR143.03-0.42 (-0.29%) ▼|FDX323.51+5.32 (+1.67%) ▲|GD349.37+2.66 (+0.77%) ▲|GE374.42+5.97 (+1.62%) ▲|GEV1,101.80+59.29 (+5.69%) ▲|GILD126.83-1.05 (-0.82%) ▼|GM77.91-0.18 (-0.23%) ▼|GOOG345.01+10.32 (+3.08%) ▲|GOOGL347.24+9.85 (+2.92%) ▲|GS1,035.93+16.32 (+1.60%) ▲|HD348.15-0.72 (-0.21%) ▼|HON248.86+5.45 (+2.24%) ▲|IBM271.02-0.61 (-0.22%) ▼|INTC124.03-4.30 (-3.35%) ▼|INTU275.49+7.77 (+2.90%) ▲|ISRG413.91+9.64 (+2.38%) ▲|JNJ254.70+0.04 (+0.02%) ▲|JPM330.35+1.30 (+0.39%) ▲|KO83.13+0.50 (+0.61%) ▲|LIN519.02-0.60 (-0.12%) ▼|LLY1,222.76+14.64 (+1.21%) ▲|LMT507.62+0.22 (+0.04%) ▲|LOW220.10-2.38 (-1.07%) ▼|LRCX389.88+10.79 (+2.85%) ▲|MA508.72+9.70 (+1.94%) ▲|MCD269.90+0.14 (+0.05%) ▲|MDLZ60.70-0.09 (-0.15%) ▼|MDT81.20+0.22 (+0.27%) ▲|META568.16+17.91 (+3.25%) ▲|MMM165.10+1.09 (+0.66%) ▲|MO73.65-0.14 (-0.19%) ▼|MRK128.07-0.59 (-0.46%) ▼|MS215.20+3.17 (+1.50%) ▲|MSFT379.04+6.07 (+1.63%) ▲|MU1,086.02-46.32 (-4.09%) ▼|NEE88.09-0.48 (-0.54%) ▼|NFLX75.47+1.66 (+2.25%) ▲|NKE41.13+0.38 (+0.92%) ▲|NOW101.84+3.50 (+3.56%) ▲|NVDA195.11+2.58 (+1.34%) ▲|ORCL152.60+4.07 (+2.74%) ▲|PEP140.79-0.60 (-0.42%) ▼|PFE24.35+0.06 (+0.23%) ▲|PG147.81-1.21 (-0.81%) ▼|PLTR118.08+5.15 (+4.56%) ▲|PM179.97-0.81 (-0.45%) ▼|QCOM190.75+1.36 (+0.72%) ▲|RTX188.95+0.96 (+0.51%) ▲|SBUX104.63+0.03 (+0.03%) ▲|SCHW91.02+0.35 (+0.38%) ▲|SO96.95-0.21 (-0.22%) ▼|SPG227.56+0.67 (+0.30%) ▲|T21.67-1.06 (-4.64%) ▼|TMO505.55-7.48 (-1.46%) ▼|TMUS175.99-6.69 (-3.66%) ▼|TSLA392.61+12.90 (+3.40%) ▲|TXN287.05+1.62 (+0.57%) ▲|UBER77.48+1.28 (+1.68%) ▲|UNH420.45-7.45 (-1.74%) ▼|UNP271.08+2.73 (+1.02%) ▲|UPS107.75-0.40 (-0.37%) ▼|USB61.07+0.16 (+0.26%) ▲|V342.34+6.11 (+1.82%) ▲|VZ44.07-2.48 (-5.32%) ▼|WFC84.07+0.21 (+0.25%) ▲|WMT116.13+0.44 (+0.38%) ▲|XOM136.37-0.18 (-0.13%) ▼|
27.6 C
New York
Monday, June 29, 2026

Tag: stage

Clarivate Launches AI-powered Regulatory Assistant Within Cortellis Suite to Boost Productivity and Ease Regulatory Burden

Integrated into Cortellis Regulatory Intelligence, new AI capability helps regulatory teams streamline access to critical intelligence and understand requirements with ease LONDON, Aug. 14, 2025...

Lumen Launches “The Talent Frontier” — A Webcast Series to Rethink Recruitment with Clarity, Empathy and Strategy

MELBOURNE, Australia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lumen has launched “The Talent Frontier,” a webcast series exploring innovative recruitment marketing and talent acquisition strategies to transform hiring. The inaugural session “AI for All: Rethinking Talent with Equity, Empathy & Automation,” sets the stage for diverse and inclusive topics in future sessions.

Piano Legend Liu Shikun and Prodigy Amy Chen Share Stage with Andrea Bocelli in Historic Sino-Italian Musical Celebration

HONG KONG, Aug. 14, 2025 /PRNewswire/ -- Chopard, the renowned Swiss luxury jeweler, hosted a transcendent musical gala against the breathtaking backdrop of Sardinia's...

NativePath Liposomal Vitamin C: Urgent 2025 Consumer Warning on Why Most Vitamin C Pills May Fail — And the 3-in-1 Formula Positioned for Better...

Public interest in vitamin C has surged in 2025 as consumers search for cleaner, more effective options beyond standard pills. Across TikTok, Reddit, and wellness forums, questions are rising about ingredient sources, absorption rates, and the difference between synthetic ascorbic acid and real, whole-food vitamin C. NativePath Liposomal Vitamin C is positioned within this growing trend, featuring an amla-based 3-in-1 formula designed for nutrient integrity and advanced delivery. It reflects a broader shift toward transparency, clean sourcing, and solutions that align with evolving health and wellness priorities.
Public interest in vitamin C has surged in 2025 as consumers search for cleaner, more effective options beyond standard pills. Across TikTok, Reddit, and wellness forums, questions are rising about ingredient sources, absorption rates, and the difference between synthetic ascorbic acid and real, whole-food vitamin C. NativePath Liposomal Vitamin C is positioned within this growing trend, featuring an amla-based 3-in-1 formula designed for nutrient integrity and advanced delivery. It reflects a broader shift toward transparency, clean sourcing, and solutions that align with evolving health and wellness priorities.

ROK Financial Streamlines Equipment Financing from $10,000 to $5 Million for All Industries

Fast, flexible funding options help businesses nationwide acquire essential equipment while preserving cash flow and supporting long-term growth.
Fast, flexible funding options help businesses nationwide acquire essential equipment while preserving cash flow and supporting long-term growth.

Northland Power Reports Second Quarter 2025 Results

TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today reported financial results for the three and six months ended June 30, 2025. All dollar amounts set out herein are in thousands of Canadian dollars, unless otherwise stated.

Nuclear Fuels Shareholders Approve Arrangement with Premier American Uranium

CSE:NFOTCQX:NFUNF TSXV:PUR OTCQB:PAUIF VANCOUVER, BC, Aug. 13, 2025 /PRNewswire/ - Nuclear Fuels Inc. ("Nuclear Fuels" or the "Company") (CSE: NF) (OTCQX: NFUNF) and Premier American Uranium...

Nuclear Fuels Shareholders Approve Arrangement with Premier American Uranium

CSE:NFOTCQX:NFUNF TSXV:PUR OTCQB:PAUIF VANCOUVER, BC, Aug. 13, 2025 /CNW/ - Nuclear Fuels Inc. ("Nuclear Fuels" or the "Company") (CSE: NF) (OTCQX: NFUNF) and Premier American Uranium...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

Conference Call 8:00am ET, Wednesday August 20, 2025 WILMINGTON, Del., Aug. 13, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a...

TENSOR UNVEILS WORLD’S FIRST PERSONAL AUTONOMOUS VEHICLE FOR PRIVATE OWNERSHIP–REDEFINING THE FUTURE WHERE YOU OWN YOUR AUTONOMY

Tensor is the only fully autonomous L4 Robocar that you can own. SAN JOSE, Calif., Aug. 13, 2025 /PRNewswire/ -- Tensor, a leading agentic...

Orla Mining Reaches Major Milestone in Nevada with Notice of Intent for South Railroad Project

Company Working with Cooperating Agencies to Fast-Track Timeline to Construction VANCOUVER, BC, Aug. 13, 2025 /CNW/ - Orla Mining Ltd. (TSX: OLA) (NYSE: ORLA) ("Orla"...

KARNALYTE RESOURCES INC. ANNOUNCES 2025 SECOND QUARTER RESULTS AND CORPORATE HIGHLIGHTS

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ SASKATOON, SK, Aug. 13, 2025 /CNW/ - Karnalyte Resources Inc. ("Karnalyte"...

Applied Therapeutics Reports Second Quarter 2025 Financial Results

- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStage